David Campany

David Campany (born 8 October 1967) is a British writer, curator, artist and educator, working mainly with photography. He has written and edited books; contributed essays and reviews to other books, journals, magazines and websites; curated photography exhibitions; given public lectures, talks and conference papers; had exhibitions of his own work; and been a jury member for photography awards. He has taught photographic theory and practice at the University of Westminster, London. Campany is Managing Director of Programs at the International Center of Photography in New York City.

His books have won the Kraszna-Krausz Foundation Book Award, Infinity Award from the International Center of Photography, Silver Award from Deutscher Fotobuchpreis and the J Dudley Johnston Award from the Royal Photographic Society.

Campany is co-founder and co-editor of ''PA'' magazine. Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'David Campany', query time: 0.01s Refine Results
  1. 1
    Physicochemical characterization of micafungin and anidulafungin for its nebulized administration

    Physicochemical characterization of micafungin and anidulafungin for its nebulized administration by Sonia Terradas-Campanario, Laura Gómez-Ganda, David Campany-Herrero

    Published 2019-09-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria

    Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria by Pablo Rubiñan, Belén Viñado, Nuria Fernández-Hidalgo, Nieves Larrosa, Abiu Sempere, David Campany, Dolors Rodríguez-Pardo, Juan José González-López, Xavier Nuvials, Ester del Barrio-Tofiño, Laura Escolà-Vergé, Ibai Los-Arcos

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. <i>Antibiotics</i> 2024, <i>13</i>, 874

    Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. <i>Antibiotics</i> 2024, <i>13</i>, 874 by Cristina Kirkegaard-Biosca, Ester del Barrio-Tofiño, Miguel Villamarín, Nieves Larrosa, David Campany, Juan José González-López, Ricard Ferrer, Belén Viñado, Laura Doménech, Julia Sellarès-Nadal, Laura Escolà-Vergé, Nuria Fernández-Hidalgo, Ibai Los-Arcos

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)—a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol

    Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabote... by Jordi Puig, Vicenç Falcó, Cristina Miranda, Francis Ruiz, Julián Olalla, Àngel Rivero, Patricia Álvarez-Lopez, Eugenia Negredo, Diana Hernández-Sánchez, Javier Jusmet, Miguel Ángel Cuerda Palomo, Ana Belén Flores de la Cruz, José Manuel Pavón, Nadia Llavero, David Campany, Vicente Faus, Claudia Broto-Cortés, Lucía Bailón, Dámaris Aguilar, David Rovira

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: